+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
RPGLIFE

RPG Life Sciences Share Price

₹2,930.70 -106.4 (-3.5%)
New 52W High in past week

01 Oct, 2026 3:59 PM (IST)

RPG Life Sciences live price: ₹2,930.70. It opened at ₹3,037 vs previous close ₹3,037; intraday high/low: ₹3,037/₹2,875. The 50 & 200 DMA stand at ₹2,749.00/₹2,454.30.

RPG Life Sciences Performance

  • Today's Low
  • ₹2,875
  • Today's High
  • ₹3,037
  • 52 Week Low
  • ₹1,733
  • 52 Week High
  • ₹3,128
  • Open Price₹3,037
  • Previous Close₹3,037
  • Volume37,126
  • 50 DMA₹2,749.00
  • 100 DMA₹2,606.70
  • 200 DMA₹2,454.30

RPG Life Sciences Chart

Investment Returns

  • Over 1 Month + 13.13%
  • Over 3 Month + 24.57%
  • Over 6 Month + 56.09%
  • Over 1 Year + 29.4%

Smart Investing Starts Here Start SIP with RPG Life Sciences for Steady Growth!

Invest Now

RPG Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 40.5
  • PEG Ratio
  • -
  • Market Cap Cr
  • 4,847
  • P/B Ratio
  • 7.6
  • Average True Range
  • 150.7
  • EPS
  • 72.3
  • Dividend Yield
  • 0.8
  • MACD Signal
  • 85.3
  • RSI
  • 55.01
  • MFI
  • 74.69

Latest Stock News Updates

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper advertisement in respect to Special window opened for lodgment of transfer and dematerialization request(s).

RPG Life Sciences Ltd - 532983 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Clarus Capital I, Others

RPG Life Sciences Ltd - 532983 - Intimation For Scheme Of Amalgamation

Intimation for Scheme of Amalgamation of Actis Generics Private Limited and their respective shareholders under section 230 to 232 and other applicable provisions of the Companies Act, 2013.

RPG Life Sciences Financials

RPG Life Sciences Technicals

EMA & SMA

Current Price
₹2,930.70
-106.4 (-3.5%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹2,862.70
  • 50 Day
  • ₹2,749.00
  • 100 Day
  • ₹2,606.70
  • 200 Day
  • ₹2,454.30

Resistance and Support

2947.57 Pivot Speed
  • R3 3,182.40
  • R2 3,109.80
  • R1 3,020.20
  • S1 2,858.00
  • S2 2,785.40
  • S3 2,695.80

RPG Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-28 Quarterly Results
2026-04-29 Audited Results & Final Dividend
2026-01-27 Quarterly Results
2025-10-17 Quarterly Results
2025-07-25 Quarterly Results
Date Purpose Remarks
2026-07-09 FINAL Rs.24.00 per share(300%)Final Dividend
2025-06-27 SPECIAL Rs.4.00 per share(50%)Special Dividend
2025-06-27 FINAL Rs.20.00 per share(250%)Final Dividend
2024-06-28 FINAL Rs.16.00 per share(200%)Final Dividend
2023-07-21 FINAL Rs.12.00 per share(150%)Final Dividend
View RPG Life Sciences Dividend History Arrow

RPG Life Sciences Shareholding Pattern

72.95%
17.42%
8.64%
0.95%
0.04%

About RPG Life Sciences

RPG Life Sciences is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). View More
  • NSE Symbol
  • RPGLIFE
  • BSE Symbol
  • 532983
  • ISIN
  • INE105J01010

Similar Stocks to RPG Life Sciences

RPG Life Sciences FAQs

RPG Life Sciences share price is ₹2,930 As on 03 October, 2026 | 00:09

The Market Cap of RPG Life Sciences is ₹4847.1 Cr As on 03 October, 2026 | 00:09

The P/E ratio of RPG Life Sciences is 40.5 As on 03 October, 2026 | 00:09

The PB ratio of RPG Life Sciences is 7.6 As on 03 October, 2026 | 00:09

The 52 week High & Low of RPG Life Sciences is ₹3127.8/₹1733 respectively As on 03 October, 2026 | 00:09

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23